rs200894780
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_000540.3(RYR1):c.3946C>A(p.Pro1316Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,599,518 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR1 | NM_000540.3 | c.3946C>A | p.Pro1316Thr | missense_variant | 28/106 | ENST00000359596.8 | NP_000531.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR1 | ENST00000359596.8 | c.3946C>A | p.Pro1316Thr | missense_variant | 28/106 | 5 | NM_000540.3 | ENSP00000352608.2 | ||
RYR1 | ENST00000355481.8 | c.3946C>A | p.Pro1316Thr | missense_variant | 28/105 | 1 | ENSP00000347667.3 | |||
RYR1 | ENST00000599547.6 | n.3946C>A | non_coding_transcript_exon_variant | 28/80 | 2 | ENSP00000471601.2 |
Frequencies
GnomAD3 genomes AF: 0.00229 AC: 349AN: 152154Hom.: 8 Cov.: 31
GnomAD3 exomes AF: 0.00278 AC: 597AN: 214766Hom.: 12 AF XY: 0.00255 AC XY: 301AN XY: 118092
GnomAD4 exome AF: 0.00103 AC: 1484AN: 1447246Hom.: 18 Cov.: 33 AF XY: 0.000989 AC XY: 711AN XY: 719044
GnomAD4 genome AF: 0.00229 AC: 349AN: 152272Hom.: 8 Cov.: 31 AF XY: 0.00347 AC XY: 258AN XY: 74444
ClinVar
Submissions by phenotype
RYR1-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Malignant hyperthermia, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 05, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | RYR1: BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at